Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 60132)    
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Scientific Management Review Board.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

*Name of Committee:*                         Office of AIDS Research Advisory Council.                    

*Date:*                         November 9, 2010.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         The theme of the meeting will be “HIV/AIDS and Adolescents.” The meeting will focus on research to address: The epidemiology of HIV infection among adolescents; HIV prevention, treatment and care for adolescents; biological and cognitive development of HIV-infected adolescents; and ethical and regulatory issues for involving youth in AIDS clinical research. An update also will be provided on the OARAC Working Groups for HIV Treatment and Prevention Guidelines.                    

*Place:*                         National Institutes of Health, 5635 Fishers Lane, Terrace Level, Rockville, MD 20852.                    

*Contact Person:*                         Robert Eisinger, PhD, Executive Secretary, Director Of Scientific And Program Operations, Therapeutics Coordinating Committee, Office of AIDS Research, 5635 Fishers Lane, Msc 9310, Suite 400, Rockville, MD 20852, (301) 496-0357,                         *be4y@nih.gov.*

Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

                        Information is also available on the Institute's/Center's home page:                         *http://www.oar.nih.gov,*                         where an agenda and any additional information for the meeting will be posted when available.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS)

Dated: September 22, 2010.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-24405 Filed 9-28-10; 8:45 am]

BILLING CODE 4140-01-P